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Fragile X syndrome (FXS), a common inherited form of mental
impairment and autism, is caused by transcriptional silencing of the
fragile X mental retardation 1 (FMR1) gene. Earlier studies have
identified a role for aberrant synaptic plasticity mediated by the
metabotropic glutamate receptors (mGluRs) in FXS. However,many
of these observations are derived primarily from studies in the hip-
pocampus. The strong emotional symptoms of FXS, on the other
hand, are likely to involve the amygdala. Unfortunately, little is
known about how exactly FXS affects synaptic function in the
amygdala. Here, using whole-cell recordings in brain slices from
adult Fmr1 knockout mice, we find mGluR-dependent long-term
potentiation to be impaired at thalamic inputs to principal neurons
in the lateral amygdala. Consistent with this long-term potentia-
tion deficit, surface expression of the AMPA receptor subunit,
GluR1, is reduced in the lateral amygdala of knockout mice. In ad-
dition to these postsynaptic deficits, lower presynaptic release was
manifested by a decrease in the frequency of spontaneous minia-
ture excitatory postsynaptic currents (mEPSCs), increased paired-
pulse ratio, and slower use-dependent block of NMDA receptor
currents. Strikingly, pharmacological inactivation of mGluR5 with
2-methyl-6-phenylethynyl-pyridine (MPEP) fails to rescue either the
deficit in long-term potentiation or surface GluR1. However, the
same acute MPEP treatment reverses the decrease in mEPSC fre-
quency, a finding of potential therapeutic relevance. Therefore,
our results suggest that synaptic defects in the amygdala of knock-
out mice are still amenable to pharmacological interventions
against mGluR5, albeit in a manner not envisioned in the original
hippocampal framework.
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Fragile X syndrome (FXS), the most common inherited form ofmental retardation, is caused by the lack of FMRP, the protein
product of the fragile X mental retardation 1 (Fmr1) gene (1–3).
A particularly useful framework for studying the cellular and
molecular underpinnings of FXS has come from the “mGluR
theory,”which proposes that various symptoms of the disorder are
triggered by a loss of translational regulation exerted by FMRP on
the group I metabotropic receptor (mGluR) signaling pathway.
One of the major findings leading to the mGluR theory is that in
the hippocampus the group 1 mGluR receptor, mGluR5, is in-
volved in long-term depression (LTD), a form of synaptic plas-
ticity that is enhanced in the Fmr1 knockout (Fmr1KO)mouse (4,
5). The underlying basis for this enhanced hippocampal mGluR-
LTD is abnormally high internalization of the AMPA receptor
(AMPAR) subunit, GluR1, caused by the absence of the end-
point inhibition normally provided by FMRP (2, 6). Interestingly,
defective AMPAR-mediated plasticity has also emerged as
a common phenotype in other brain areas in the Fmr1KOmouse,
including the cortex and cerebellum (7–11). However, such defi-
cits are not limited to LTD, but are also frequently manifested as
an impairment of long-term potentiation (LTP) (7, 12–15). Such
LTP, expressed through AMPAR-dependent currents, does not
always involve mGluR5 in its induction (8, 12, 16).
A majority of the observations contributing to the mGluR
theory are derived from studies focusing primarily on the hippo-
campus and cortex (4, 7, 13, 14). The strong emotional symptoms
of FXS, on the other hand, are likely to involve the amygdala (2,
13, 17). Unfortunately, little is known about the impact of FXS on
synaptic function in the amygdala. This lack of knowledge, in turn,
limits our ability to interpret earlier behavioral studies on anxiety
and fear in the Fmr1KOmouse, which have yielded mixed results
that are not consistent with the enhanced emotional symptoms
observed in the human disease (17–20). Furthermore, whether or
not synaptic abnormalities in the amygdala are consistent with the
mGluR theory also remains unexplored. This issue is particularly
relevant in light of previous reports on the contrasting nature of
mGluR-dependent synaptic plasticity in the hippocampus versus
amygdala. In area CA1 of the hippocampus, mGluR5 is involved
in LTD, which is enhanced in Fmr1 KO mice. In the lateral
amygdala (LA), by contrast, mGluR5 mediates LTP. If the
mGluR theory holds true in the amygdala, then it would predict
the excessive mGluR signaling to cause enhanced mGluR-LTP in
the LA of Fmr1 KO mice. However, the same form of LTP (21)
underlies classical fear conditioning, which, according to some
reports, is impaired in Fmr1 KO mice (17). This raises the pos-
sibility that mGluR-LTP too is impaired in the LA of mutant
mice, which is opposite to the enhancedmGluR-LTP predicted by
the mGluR theory. On the other hand, more recent studies in the
hippocampus have shown that enhanced mGluR signaling leads
to a reduction in surface levels of AMPARs; if a similar mecha-
nism is in play in the amygdala, it could work against the stabili-
zation of LTP in the LA (7, 14). A better understanding of the
state of synaptic transmission and plasticity in the amygdala of
mutant mice is needed to examine these divergent predictions.
Therefore, the aim of the present study is to address some of these
key issues within the broader context of the mGluR theory, using
a combination of electrophysiological and biochemical analyses in
the lateral amygdala of adult Fmr1 KO mice.
Results
LTP Is Impaired at Thalamic Afferents to the LA in Fmr1 KO Mice.We
first focused on a key prediction of the mGluR theory by in-
vestigating if mGluR-LTP is indeed enhanced in the LA of Fmr1
KO mice. To this end, we used whole-cell recordings to monitor
excitatory postsynaptic potentials (EPSPs) evoked by stimulation
of thalamic inputs to LA pyramidal cells in brain slices prepared
from adult mice. In LA slices from WT mice, two trains of 100
pulses at 30 Hz led to robust LTP (average EPSP slope at
minutes 40–45; 1.42 ± 0.13, numbers as mean ± SEM, normal-
ized to baseline, n = 6). In WT slices, similar to reports in rats
(21), this LTP was completely blocked by the specific mGluR5-
antagonist 2-methyl-6-phenylethynyl-pyridine (MPEP, 40 μM)
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(Fig. S1E). Strikingly, the same induction protocol failed to elicit
any significant LTP in slices prepared from mutant littermates
(1.03 ± 0.09, n= 6), (Fig. 1 A and B). Thus, in contrast to greater
mGluR-LTD seen in the hippocampus, mGluR-LTP is impaired
in the LA of Fmr1 KO mice.
Next, we examined if this LTP deficit could be caused by ab-
normal action potential firing in LA neurons, because mGluRs
are known to underlie pathological firing patterns in the hippo-
campus of Fmr1 KO mice (22). We detected no difference in
EPSP-Spike (E-S) coupling, an index of the probability of firing an
action potential for a given synaptic strength (Fig. S1 A and B).
Furthermore, action potentials, evoked by somatic injection of
depolarizing currents, did not differ between KO and WT cells
(Fig. S1 C and D), suggesting that deficits in postsynaptic excit-
ability are unlikely to interfere with the induction of LTP in the
LA of Fmr1 KO mice.
Surface GluR1 Is Reduced in the LA of Fmr1 KO Mice. Does this im-
pairment, instead of enhancement, of mGluR-dependent syn-
aptic plasticity in the amygdala of Fmr1 KO mice contradict the
mGluR theory? Recent studies have shown that the debilitating
impact of excess signaling through mGluR5, caused by a loss of
the translational repressor FMRP, is manifested in the hippo-
campus as enhanced internalization of the AMPAR subunit,
GluR1 (6, 9, 23); it is this abnormally high AMPAR internal-
ization that leads to greater hippocampal mGluR-LTD in Fmr1
KO mice. If a similar mechanism is in play in the amygdala, it
would undermine the stabilization of LTP by impairing insertion
of AMPARs into synapses. We examined this possibility by quan-
tifying levels of biotin-labeled surface GluR1 in basolateral
amygdalar slices from Fmr1KO andWTmice by comparing both
biotinylated GluR1 and total GluR1 protein. We found a re-
duction in GluR1 surface expression in Fmr1 KO mice (KO:
73.2 ± 7.9%, n = 11; WT: 100 ± 7.2%, n = 9), (Fig. 1 C–E).
Importantly, the difference was specific to surface-labeled GluR1
because total GluR1 protein was not different between WT and
KO mice (KO: 99.9 ± 7.5%; WT: 100 ± 2.4%). Thus, although
the direction of activity-induced change in synaptic strength and
its aberration in Fmr1KOmice are opposite in the LA compared
with the hippocampus, the reduction in AMPAR surface ex-
pression in the amygdala is in agreement with earlier findings in
the cortex and hippocampus in Fmr1 KO mice (6, 7).
The mGluR-Specific Inverse Agonist MPEP Fails to Rescue the LTP
Deficit in the LA. The mGluR theory also proposes that inhibiting
mGluR-activity should reverse defects observed in the Fmr1 KO
mice. We tested this by repeating the same 30-Hz LTP experi-
ments in KO slices that were preincubated for 1 h in 40 μMMPEP,
an mGluR5-specific inverse agonist, at concentrations that have
earlier been used to reverse phenotypes in the Fmr1 KOmice (6).
Surprisingly, treatment with MPEP failed to reverse the impaired
LTP observed in LA neurons from KO mice (normalized EPSP
slope at minutes 30–35; WT: 1.41 ± 0.11; KO: 0.98 ± 0.11, n = 6;
KO+MPEP: 1.11 ± 0.06, n= 5) (Fig. 2A). To further analyze this
apparent contradiction of the mGluR theory in the amygdala, we
took note of earlier findings from other brain areas of Fmr1 KO
mice exhibiting deficient forms of LTP that are not necessarily
dependent on mGluR5 (7, 10, 11, 15, 16). Because restoration of
AMPARs to the surface could also be mediated by other non-
mGluR plasticity mechanisms, we wanted to ensure that con-
tributions from such mechanisms are not constrained by our use of
the 30 Hz mGluR-LTP induction protocol alone. Hence, to rule
out the possibility that the 30-Hz stimuli may not be robust enough
to recruit and stabilize AMPARs to the surface (16), we increased
the frequency of tetanic stimulation to 100 Hz (24). In WT cells,
this resulted in greater magnitude of LTP (1.74 ± 0.19, n = 5)
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Fig. 1. mGluR5-dependent LTP is absent and surface GluR1 is reduced in the
amygdala of Fmr1 KO mice. (A) High-frequency stimulation at 30 Hz (arrow)
induces LTP in LA slices from WT mice but not Fmr1 KO siblings. (Insets)
Average of 10 traces before tetanus and up to 45th minute: (i) WT (ii) KO.
(Scale bars: 5 mV, 50 ms.) (B) Mean values of LTP from minutes 40 to 45,
normalized to the 5-min pretetanus baseline. *P = 0.033 (number of cells).
(C) Surface expression of GluR1, determined by pull-down of biotin-labeled
receptor, is reduced in KO mice. *P = 0.024, (number of mice). (D) Total
GluR1 is not different. (E) Representative Western blots are shown. Surface
GluR1 is normalized to avidin, and total GluR1 to GAPDH. FMRP is absent in
tissue from KO mice.
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Fig. 2. Neither the LTP deficit nor reduction in surface GluR1 is rescued by
MPEP. (A) MPEP (40 μM) treatment fails to rescue deficit in 30 Hz-LTP in KO
cells. Mean values of LTP from minutes 30 to 35, normalized to the 5-min
baseline. *P = 0.019. (Number of cells) (B) MPEP preincubation does not
change surface or total GluR1 levels in KO mice. (Number of mice) (C) LTP
induced by 100-Hz tetanic stimuli (arrow) in WT slices is greater than KO
slices; this deficit is not reversed by MPEP treatment. (Insets) Average of 10
traces before tetanus and up to 35th minute: (i) WT (ii) KO. (Scale bars: 5 mV,
50 ms.) (D) Mean values of LTP from minutes 30 to 35, normalized to 5-min
pretetanus. One-way ANOVA *P = 0.022, post hoc Tukey’s HSD P values: WT-
KO = 0.034, WT-KO+MPEP = 0.042 (number of cells).
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(Fig. 2C) at thalamic inputs compared with the earlier 30-Hz
protocol. Even this robust form of LTP was still significantly sup-
pressed in Fmr1 KO neurons and was not reversed by MPEP
preincubation (normalizedEPSP slope atminutes 30–35; KO: 1.19
± 0.12, n = 5; KO+MPEP: 1.21 ± 0.08, n = 5), (Fig. 2 C and D).
Reduction in Surface GluR1 Is Also Not Reversed by MPEP in the LA of
Fmr1 KO Mice.Wenext probed the underlying basis of this failure to
rescue impaired LTP in the LA of Fmr1 KO mice by quantifying
surface GluR1 after preincubation with MPEP. Again, as with the
LTP experiments, amygdalar slices from Fmr1 KO mice were
preincubated for a period of 1 h in either 40 μMMPEP or vehicle.
Strikingly,MPEP failed to restoreAMPARs to the surface (surface
GluR1; KO+vehicle: 100 ± 1.2%, n = 7; KO+MPEP: 74.78 ±
12.4%, n=7), or to change totalGluR1 (KO+vehicle: 100± 7.8%;
KO+MPEP: 121.9 ± 12.1) (Fig. 2B). These results explain why
postsynaptic expression of LTP in Fmr1 KO mice is disrupted
irrespective of the strength of the induction protocol. We also
tested if this lack of effect was because of variations in mGluR5
plasticity or expression in the amygdala. In contrast to the hippo-
campus (23, 25), bath application of the group 1 mGluR-agonist
dihydroxyphenylglycine (DHPG) (50 μM) in LA slices did not af-
fect frequency and amplitude of spontaneous miniature AMPAR-
mediated EPSCs, (mEPSCs) (Fig. S2 A and B). Levels of mGluR5
receptors were not different betweenKOandWT slices (Fig. S2C).
Thus, mGluR5 receptors are available at comparable levels for
MPEP to act; the effects of the selective agonist, however, appear
to differ.
LA Neurons from KO Mice Exhibit Both Post- and Presynaptic Deficits
in Excitatory Synaptic Transmission. Despite identifying a clear
impairment in synaptic plasticity, the results presented thus far
provide no insights into the overall status of basal synaptic
transmission in the amygdala in the Fmr1KObrain.Moreover, we
have no corroboration of the electrophysiological consequences
of the postsynaptic deficit in the levels of surface AMPARs.
Therefore, we compared the frequency and amplitude of mEPSCs
in LA slices from KO and WT mice (Fig. 3 A–C). Miniature
AMPAR-mediated EPSCs were recorded in the presence of te-
trodotoxin (TTX) and picrotoxin, and were completely blocked by
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), showing that they
were AMPAR-dependent synaptic currents (Fig. S1F). Fmr1 KO
neurons exhibited a significant reduction in mEPSC frequency
(WT: 0.68± 0.13 Hz, n=22; KO: 0.2± 0.03Hz, n=20) (Fig. 3B),
as well as amplitude (WT: 23.4 ± 0.77 pA; KO: 20.8 ± 0.4 pA)
(Fig. 3C). Although the decrease in mEPSC amplitude together
with the reduction in surface AMPARs points to postsynaptic
deficits, the decrease in mEPSC frequency in KO cells may be
indicative of presynaptic effects. To ensure that this deficit was
specifically present at the thalamic inputs where we earlier found
LTP to be impaired, thalamic afferents were stimulated and ex-
tracellular Ca2+ was replaced with Sr2+, resulting in an evoked
synchronous EPSC along with a barrage of desynchronized min-
iature EPSCs (SrEPSCs) (Fig. 3D, Inset). SrEPSC amplitude was
significantly reduced in KOmouse slices (WT: 23.96± 0.8 pA, n=
6; KO: 21.65 ± 0.5 pA, n = 8). Therefore, the deficit in surface
AMPARs was indeed present at the thalamic synapses in the LA.
Having obtained biochemical and electrophysiological meas-
ures of postsynaptic deficits that are in agreement, we turned our
attention to the reduction in mEPSC frequency in LA neurons in
the Fmr1 KO mice, which is suggestive of changes in presynaptic
release probability. To test this possibility we measured paired-
pulse ratios across a range of interstimulus intervals, at the tha-
lamic inputs to the LA. We found paired-pulse facilitation ratios
of evoked EPSCs are greater in KO mice compared with the ab-
sence of paired-pulse facilitation in WT mice, indicating a re-
duction in release probability in Fmr1 KO neurons (WT: n = 6;
KO: n = 6) (Fig. 3E). The reduction in mEPSC frequency, along
with greater paired-pulse facilitation ratios, warrants a more rig-
orous analysis of the decrease in probability of release (Pr), es-
pecially because no such presynaptic effect has been reported in
the hippocampus. Hence, thalamic inputs to the LA were re-
peatedly stimulated in the presence of the NMDAR open-chan-
nel blocker (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,
d]cyclohepten-5,10-imine maleate (MK-801). This led to a pro-
gressive decay of NMDAR-EPSCs (Fig. 3F), the time constant of
which is inversely related to Pr. The decay kinetics were fit by
a double exponential, and the fast time-constant of decay (τf)
compared across groups (26, 27). MK-801 blockade led to
a slower τf, implying a lower Pr in KO cells [WT: 0.78 ± 0.32, n=
7; KO: 1.86 ± 0.24, n = 7 (stimuli); P < 0.05] (Fig. 3F).
MPEP Reverses Reduction in mEPSC Frequency but Not mEPSC
Amplitude in the LA. Taken together, the electrophysiological
and biochemical data presented so far point to both pre- and
postsynaptic deficits in Fmr1 KO neurons. Although MPEP did
not reverse deficits in postsynaptic surface AMPARs in the LA,
could it nonetheless rescue the presynaptic deficit in release
probability? We investigated this by repeating the mEPSC
recordings in KO slices that were preincubated for 1 h in 40 μMof
MPEP. Surprisingly, MPEP was indeed able to return mEPSC
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Fig. 3. LA cells exhibit reduced frequency and amplitude of mEPSCs, en-
hanced paired-pulse facilitation, and slower MK-801-induced decays in Fmr1
KO mice. (A) Sample mEPSC traces. (Scale bar: 20 pA, 1s.) (B) Summary of
change in frequency. **P = 0.002. (C) Summary of change in amplitude. **P =
0.005. (D) Strontium-desynchronized events evoked by stimulation of tha-
lamic inputs to the LA show reduced amplitude in KOmice. *P = 0.029. (Inset)
Sample traces. (Scale bars: 50 pA, 0.02 s.) (E) Enhanced paired-pulse facilita-
tion in KO (○) compared with WT cell (●). **P = 0.006, (repeated measures
ANOVA). (Inset) Sample of averaged EPSC traces at 100-ms interstimulus in-
terval. (Scale bars: 20 pA, 0.05 s.) (Number of cells). (F) Release probability is
lower at thalamic inputs to LA in KO mice. Normalized amplitude of the
NMDA-EPSC is plotted after bath application of 40 μM MK-801. Progressive
block of the NMDA-EPSC byMK-801 is slower at KO synapses (gray) compared
with WT synapses (black) in the LA. (Inset) Sample traces of first five EPSCs in
MK-801. (Scale bars: 50 pA, 0.02 s.)
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frequency in Fmr1KO neurons to levels not significantly different
fromWTneurons (WT: 0.68± 0.13Hz, n=22; KO: 0.2± 0.03Hz,
n= 20; KO+MPEP: 0.48± 0.02 Hz, n=13) (Fig. 4 A andC); but
mEPSC amplitude was not altered byMPEP (WT: 23.4± 0.77 pA;
KO: 20.8 ± 0.4 pA; KO+MPEP: 22 ± 0.72 pA) (Fig. 4 B and D).
Although the lack of reversal of amplitude in Fmr1 KO neurons
supports our earlier observation on the lack of recovery of
AMPARs to the surface with the biotinylation assay (Fig. 2B), the
reversal of the mEPSC frequency deficit in Fmr1 KO neurons
implicates changes in presynaptic release that are amenable to
rescue by MPEP treatment.
Discussion
Although the results presented herein are consistent with certain
aspects of the mGluR theory, they also underscore the need to
modify the existing framework to better explain synaptic dys-
function in the amygdala in a mouse model of FXS, where
mGluR-signaling differs from the hippocampus (2). The mGluRs
in the LA are involved in LTP, not LTD (Fig. 5) (21). Further-
more, hippocampal mGluR-LTD is larger in KO mice (4), but we
report the opposite effect in the amygdala. Another prediction of
the mGluR theory also does not hold up in the amygdala: neither
the LTP deficit, nor the reduced surface expression of AMPARs,
was rescued byMPEP treatment (Fig. 5). Yet, despite its failure to
reverse the postsynaptic defects, MPEP treatment for the same
duration was able to reverse mEPSC frequency in the LA. In
contrast, in the hippocampus, MPEP treatment rescues the
postsynaptic deficit in surface AMPARs (6), but no presynaptic
changes in transmitter release have been reported in Fmr1 KO
mice (Fig. 5).
Despite these contrasts, we find a common endpoint underlying
synaptic defects in the amygdala and other brain regions. Our
analysis uncovers the same deficit in surface AMPARs in the LA
(Fig. 5). The significant reduction inAMPAR surface expression, in
turn, works against the establishment of robust LTP in the LA,
irrespective of the strength of the induction protocol. This finding is
also in agreement with studies reporting suppression of LTP caused
by impaired surface delivery of AMPARs in the cortex of Fmr1KO
mice (8). In the hippocampus, however, AMPAR-internalization
triggered by mGluR-LTD adds to the reduced surface AMPARs in
Fmr1 KO cells to give rise to greater LTD (Fig. 5).
Our results also point to additional differences between the
amygdala and hippocampus within the broader context of the
mGluR theory and FXS. For example, the basal level of surface
AMPARs is lower in the LA of KO mice, but in the hippo-
campus earlier results appear to be mixed (6, 28). However, both
of these studies have relied on acute molecular manipulations in
cultured hippocampal neurons that are likely to differ from brain
tissue in which disease-induced changes have stabilized over the
course of development into adulthood. Thus, the synaptic defects
identified herein are likely to reflect changes linked directly to
the loss of FMRP, as well as homeostatic changes compensating
for such synaptic dysfunction. Future studies will be needed to
examine if the pre- and postsynaptic deficits reported here evolve
in a particular sequence or in parallel.
Although earlier studies have focused on postsynaptic defects,
the reduction of mEPSC frequency, and its reversal with MPEP,
highlight the need to further investigate changes in presynaptic
release probability in the LA of Fmr1 KO mice. This issue is
noteworthy for several reasons. Past studies on cellular pheno-
types of the Fmr1 KO mouse have focused largely on post-
synaptic aberrations. In contrast to our results, no presynaptic
effects have been reported in the hippocampus or cortex of KO
mice. Moreover, in the LA, mGluR5 is localized to the post-
synaptic side (21). Therefore, an important question arises: how
does postsynaptic mGluR5 provide a basis for presynaptic defi-
cits and their reversal in KO slices? Not enough is known to
answer this question in the amygdala, but earlier studies in the
hippocampus suggest possible mechanisms. For example, acti-
vation of postsynaptic mGluR5 and p38 MAP kinase leads to
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a reduction in presynaptic release in the hippocampus (29–31).
Of particular relevance to the present study is the existence of
a developmental switch for pre- versus postsynaptic changes in
hippocampal mGluR-LTD (27). Specifically, although mGluR-
LTD at neonatal synapses results in a significant reduction in
presynaptic release probability without any postsynaptic effects,
at mature synapses it causes a decrease in AMPAR surface ex-
pression without any detectable change in presynaptic function
(27). In the hippocampus, this framework has been used to show
that mGluR-LTD in Fmr1 KO mice is the mature, postsynaptic
form (32). By contrast, in the adult LA we observe reduced
AMPAR surface expression to coexist with lower mEPSC fre-
quency, which is indicative of a decrease in release probability.
Thus, what is seen as a “neonatal” deficit in presynaptic function
in the hippocampus may not undergo the same developmental
switch in the mature amygdala, and thereby continue to function
like a developmentally arrested immature synapse. This in turn is
consistent with the view that a hallmark of FXS is deficient
synaptic maturation (33, 34).
Even with the divergent manifestations of abnormal synaptic
transmission and plasticity in the amygdala versus hippocampus,
our results suggest that synaptic defects in the amygdala of Fmr1
KO mice are still amenable to pharmacological interventions
against mGluR5, albeit in a manner not envisioned in the orig-
inal framework of the mGluR theory. This theory is noteworthy
in light of the previously reported reversal of behavioral deficits
by MPEP (35). Hence, future studies based on this framework
will have to take into account both pre- and postsynaptic effects,
as well as their brain region-specific variations. Despite these
challenges, of particular significance is our finding that even
a relatively brief treatment with an mGluR5-antagonist is capa-
ble of correcting a key aspect of deficient transmission on the
presynaptic side that has received relatively little attention in
earlier studies. A genetic approach has previously been used to
prevent FXS symptoms in mice through chronic reduction in
mGluR expression from birth (36), but our results raise the ex-
citing possibility that this reversal can be achieved pharmaco-
logically even after the disease has had months to leave its mark
in the adult brain.
Materials and Methods
Animals. Adult Fmr1 KOmice andWT siblings were provided by the Tonegawa
and Bear laboratories at the Picower Centre for Learning and Memory, Mas-
sachusetts Institute of Technology (MIT, Cambridge, MA). Animals were gen-
otyped inMIT, aspreviously described (37). Theywerehousedwith siblingswith
a 14-h/10-h day/night cycle with ad libitum access to food and water.
Slice Preparation. Male Fmr1 KO mice or age-matched WT siblings (3.5–6 mo
old) were used following National Centre for Biological Sciences/New York
University institutional Animal Ethics Committee-approved procedures. Ani-
mals were anesthetized with Halothane, cervically dislocated, and de-
capitated. The brain was dissected under ice-cold artificial cerebrospinal fluid
(aCSF: 124mMNaCl, 2.7 mMKCl, 2 mMCaCl2, 1.3 mMMgCl2, 26mMNaHCO3,
0.4mMNaH2PO4, 18mMglucose and 4mMascorbate; pH 7.3, 290mOsm) and
whole-brain coronal slices (350 μm) obtained using a Vibratome 1000 Plus.
Slices were transferred to a submerged chamber containing aCSF equilibrated
with 95%O2 and 5% CO2. The slices were incubated at room temperature for
at least 1 h before being transferred to a superfused recording chamber.
In Vitro Slice Electrophysiology. Whole-cell recordings were performed at 28
to 30 °C for all mEPSC, PPF, SrEPSC, and E-S coupling experiments. Slices were
held at 24 °C for LTP andMK-801 recordings. Neurons were visually identified
with infrared videomicroscopy using an upright microscope equipped with
a 60× objective (Olympus BX50WI, water immersion lens, 0.9 N.A.). Patch
electrodes (3-6 MΩ) were pulled from borosilicate glass tubing and filled with
a solution containing 120mMpotassium gluconate, 20mMKCl, 10mMHepes
buffer, 10mMphosphocreatine, 4mMMg-ATP, and 0.3mMNa-GTP (pH 7.25;
295 mOsm). For voltage-clamp experiments, potassium was replaced by
equimolar cesium. In current-clamp recordings,membrane potential was kept
manually at −74 mV. Data were recorded with an HEKA EPC9 (HEKA Elek-
tronik) amplifier, filtered at 2.9 kHz and digitized at 10 kHz. Monosynaptic
EPSPs or EPSCs were elicited by stimulation of thalamic afferent fibers with
a bipolar twisted platinum/iridium wire (2 × 25 μm, FHC, Bowdoin). Series
resistance was monitored throughout the experiment by applying hyper-
polarizing current or voltage pulses, was less than 25 MOhms and did not
change by more than 10% for mEPSC and desynchronized EPSC recordings
and 25% for LTP and MK-801 recordings.
Long-Term Potentiation. High-frequency stimulation consisted of two trains of
100 pulses at 30 Hz, 20 s apart. Experiments were performed in 100 μM pic-
rotoxin, and cortical inputs were cut off. Stimulation was at 0.05 Hz, and each
minute was averaged for Figs. 1A and 2C. LTP was quantified for statistical
comparisons by averaging and normalizing EPSP slopes during minutes 40 to
45 and minutes 30 to 35 to the 5-min baseline. For 100 Hz LTP, coronal slices
were intact, and tetanus was one train of 200 pulses at 100 Hz. Quantification
of LTP was by comparison of minutes 30 to 35 normalized to the 5-min
baseline. Slopes were quantified using Igor Pro (Wave Metrics Inc.), setting
cursors within the 10 to 90 range of EPSP slope during the baseline. The same
cursor settings were maintained for slope measurements over the entire
post-LTP time course. For LTP reversal experiments, coronal slices were pre-
incubated in aCSF containing 40 μM MPEP for 1 h, before incubating in the
recording chamber without MPEP for at least 15 min.
mEPSCs. For mEPSC experiments, 5 continuous min were used for analysis,
beginning at least 4 min after the whole-cell recording configuration had
beenestablished.Experimentswereperformed in100μMpicrotoxinand0.5μM
TTX and analyzed using MiniAnalysis (Synaptosoft Inc.). The mEPSCs were
completely blocked by 10 μM CNQX (Fig. S1F).
Paired-Pulse Ratios. Paired-pulse ratios were determined as the ratio of am-
plitudes of the second EPSC to the first, for a range of interstimulus intervals.
Strontium-Desynchronized EPSCs. LA cells held were at −70 mV and thalamic
afferents were stimulated in the presence of 100 μM picrotoxin and 0.5 μM
TTX. 2 mM Ca2+ in the aCSF was replaced with 2 mM Sr2+ and the initial
synchronous EPSC decreased in size in parallel with an appearance of SrEPSCs
(38, 39). EPSC amplitude stabilized in ≈15 min, and stimulation frequency was
2 Hz for 10 traces, repeated every 20 s (25). Asynchronous events were
measured offline during the 740-ms period after stimulus, using MiniAnalysis
(Synaptosoft Inc.). Desynchronized events were subjected to visual confir-
mation and 100 events were randomly selected from each cell for
amplitude analysis.
MK-801–Induced Decays of NMDAR Currents.NMDAR receptor mediated EPSCs
evoked by thalamic stimulation were recorded at +40 mV in the presence of
10 μM CNQX and 100 μM picrotoxin. EPSCs were elicited every 15 s (26, 40).
Next, 40 μMMK-801 was added to the perfusate and stimulation was paused
for 10 min to allow it to equilibrate (26, 40). Stimulation was then resumed
and the decay of NMDAR EPSC amplitudes measured. EPSC amplitudes were
normalized to the first trace in MK-801. The first 30 traces of progressive
blockade was fit to a double exponential in IgorPro. MK-801–induced
NMDA-EPSC decays were the same for C57BL/6 mice and WT siblings, and
these values were pooled before comparison with KO mice.
Statistical Analyses. All values are expressed as mean ± SEM. Statistical
comparisons were done after using Levene’s test and single sample K-S test
for appropriate assumptions of variance and normality of distribution.
Comparisons between two groups used the Student’s t test. Multiple group
comparisons for mEPSCs were done using one-way ANOVA, with the Welch
statistic for unequal variances (41), followed by post hoc Tukey’s or Games-
Howell pairwise tests. Distributions were compared using the K-S test.
Reagents. Picrotoxin and CNQX were obtained from Sigma-Aldrich. MPEP hy-
drochloride was a gift from FRAXA Research Foundation, TTX was from Alo-
mone Labs. MK-801maleate andDHPGwere obtained from Tocris Biosciences.
Biochemical Analysis of Surface and Total GluR1. Amygdalar slice preparation.
Micewerekilled and coronal slices (400μm)wereobtainedusingaLeicaVT1200
microtome and cutting solution (inmM: 110 sucrose, 11.6 Na L-ascorbic acid, 60
NaCl, 2.5 KCl, 25NaHCO3, 1.25NaH2PO4, 7MgCl2, 2.5 D-glucose, 0.5 CaCl2). Slices
containing amygdala were allowed to recover for 30 min in saturated 95%
O2:5% CO2 solution of 50:50 cutting solution:aCSF (in mM: 125 NaCl, 2.5 KCl, 25
NaHCO3, 1.25NaH2PO4, 1MgCl2, 25 D-glucose, 2 CaCl2) at 25 °C. Sliceswere then
transferred to aCSF at 32 °C for 1 h incubation before labeling. For MPEP
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treatment, following recovery sliceswere incubatedwith 40 μMMPEP or vehicle
(aCSF) for 60 min before biotin surface labeling. Slice biotinylation, streptavidin
pull-down, and Western blotting were done following standard procedures,
using the antibodies listed below. Details of the procedures are described in SI
Materials and Methods. Data represent mean + SEM.
Antibodies. Antibodies used were: goat anti biotin-HRP (Pierce) 1:500; mouse
anti-MAP2 (Abcam) 1:2,000; goat anti-mouse-HRP (Promega) 1:5,000; mouse
anti-avidin (Abcam) 1:5,000; rabbit anti-GAPDH (Novus) 1:10,000; mouse anti-
FMRP (Chemicon) 1:1,000; rabbit monoclonal anti-mGluR5 (Novus) 1:1,000;
goat anti-rabbit-HRP (Promega) 1:5,000.
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